Kestra Medical CCO receives 58,832 vested shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies Chief Commercial Officer Alfred J. Ford Jr. acquired 58,832 Common Shares on July 15, 2026 at $0.00 per share. The shares were earned from performance-based RSUs granted July 17, 2025, which vested 100%, bringing his direct holdings to 133,471 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares F1 | 58,832 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026.
Key Figures
Key Terms
performance-based RSUs financial
PSUs financial
vested financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did KMTS report for Alfred J. Ford Jr.?
On what dates were the KMTS PSUs granted and when did they fully vest?
Was the KMTS insider transaction by Alfred J. Ford Jr. under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.